Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04880200 · ClinicalTrials.gov registry record · NA
Improving HIV Diagnosis, Linkage to Care, and Prevention Services With HIV Point-of-Care Nucleic Acid Tests
A NA study, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 932
- Enrollment target
NCT04880200 is a NA study that is actively recruiting participants, run by University of Washington. The registered enrollment target is 932 participants.
The verdict
NCT04880200, a NA study, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 932 participants
- Enrollment target
Study Summary
This project will develop, implement, and evaluate models for use of point-of-care nucleic acid testing (POC NAT) among HIV-negative persons seeking HIV testing, PEP, and PrEP and HIV-positive persons in community and clinical settings. Study aims #1 and #2 will evaluate the sensitivity and specificity of a qualitative POC NAT in persons not known to be HIV-positive and will determine the impact of its use on PrEP uptake and persistence among persons testing HIV-negative and on time to HIV continuum of care outcomes among persons testing HIV-positive. Aim #3 will implement a POC NAT-tailored behavioral intervention to evaluate impact on time to virologic suppression among PLWH receiving ART. Aim #4 will quantify the acceptability and feasibility of implementation of POC NAT in community and clinical settings and collect cost and related data for cost-effectiveness analyses. Finally, in Aim #5, a distinct but related study will compare the sensitivity, specificity, and agreement of multiple POC NATs over a range of HIV RNA levels.
Interventions
- DIAGNOSTIC_TEST POC NAT & Adherence Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 932 participants |
| Start Date | 2022-01-03 |
| Est. Completion | 2024-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04880200
The ClinicalTrials.gov registry entry for NCT04880200 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 932 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which POC NAT & Adherence Intervention is the first listed.
NCT04880200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04880200 about?
NCT04880200 is a clinical study titled "Improving HIV Diagnosis, Linkage to Care, and Prevention Services With HIV Point-of-Care Nucleic Acid Tests". This project will develop, implement, and evaluate models for use of point-of-care nucleic acid testing (POC NAT) among HIV-negative persons seeking HIV testing, PEP, and PrEP and HIV-positive persons in community and clinical settings. Study aims #1 and #2 will evaluate the sensitivity and specific...
What is the current status of trial NCT04880200?
This trial is currently recruiting. It is a NA study. The enrollment target is 932 participants. The study started on 2022-01-03. Estimated completion is 2024-08-31.
What interventions are being tested in trial NCT04880200?
The interventions under investigation include: POC NAT & Adherence Intervention (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04880200?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.